FDA Drug/Biologics Approval BLA 125522 S-001, EVOLOCUMAB

FDA Drug/Biologics Approval BLA 125522 S-001, EVOLOCUMAB

Regular price $149.00 USD
Regular price Sale price $149.00 USD
Sale Sold out
BLA 125522 S-001
Company: AMGEN INC
Drug Name: REPATHA
Active Ingredients: EVOLOCUMAB
Strength: 140MG/ML
Dosage Form/Route: INJECTABLE;INJECTION
Action Date: 08/27/2015
Marketing Status: Prescription
Submission Classification: ORIG-1

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details